Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile.
Mutations in rpoB are associated with rifampin and rifaximin resistance in C. difficile
High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital.
All rifampin-resistant isolates contained the R505K substitution
rpoB
Clostridioides difficile rpoB with mutation conferring resistance to rifampicin; CARD accession: CARD:3004563
Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages.
A Clostridium difficile Lineage Endemic to Costa Rican Hospitals Is Multidrug Resistant by Acquisition of Chromosomal Mutations and Novel Mobile Genetic Elements.
rifampin resistance
Genomic evolution and virulence association of Clostridioides difficile sequence type 37 (ribotype 017) in China.
Mutations in rpoB associated with rifampicin resistance
A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile.
Associated with rifamycin resistance
Clostridioides difficile evolution in a tertiary German hospital through a retrospective genomic characterization.
Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile.
Global evolutionary dynamics and resistome analysis of Clostridioides difficile ribotype 017.
Molecular Epidemiology and Antimicrobial Resistance of Clostridioides difficile in Hospitalized Patients From Mexico.
Molecular epidemiology of Clostridioides difficile in companion animals: Genetic overlap with human strains and public health concerns.
Detected in one isolate.
Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms.
High-resolution melting analysis of the single nucleotide polymorphism hot-spot region in the rpoB gene as an indicator of reduced susceptibility to rifaximin in Clostridium difficile.
Clostridioides difficile rpoB with mutation conferring resistance to rifampicin; CARD accession: CARD:3004563
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research